Latest news
CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 13:03:00 GMTScholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date - BioSpaceBioSpace · Mon, 10 Aug 2026 02:16:42 GMTApplied Biologics Receives Central IRB Approval for Phase 3 BIOxHEAL™ Clinical Trial - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 11:38:16 GMTApplied Biologics Marks 10 Years of Continuous AATB Accreditation While Initiating Reaccreditation Process - The Manila TimesThe Manila Times · Tue, 04 Aug 2026 20:09:25 GMTApplied Biologics Announces Successful GMP Manufacturing of Initial Clinical Lots of BIOxHEAL™ - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTApplied Biologics Expands National Commercial Payer Engagement Strategy for XWRAP® - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 13:56:29 GMT